RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-mediated transformation, by profiling two human ovarian epithelial cell lines. One cell line was immortalized with SV40 T/t antigens and the human catalytic subunit of telomerase (T29), while the second cell line was transformed with an additional oncogenic ras V12 allele (T29H). In total, 32 proteins associated with RAS-mediated transformation have been identified using peptide mass fingerprinting. These protein targets are involved in several cellular pathways, including metabolism, redox balance, calcium signaling, apoptosis, and cellular methylation. One such target, the 40 kDa procaspase 4 is significantly upregulated at the protein level in RAS-transformed T29H cells, related directly to signaling through MEK, but not PI3 kinase. Cellular caspase 4 activity is, however, suppressed in the T29H cells, suggesting that the maturation process of caspase 4 is abrogated in RAS-transformed T29H cells. Consistent with this notion, transformed T29H cells were less susceptible to the toxic effects of anti-Fas antibody than were immortalized, nontransformed T29 cells, associated with less activation of caspase 4. This study demonstrates that functional proteomic analysis of a genetically defined cancer model provides a powerful approach toward systematically identifying cellular targets associated with oncogenic transformation.
Introduction
Normal cells in the body are programmed by a variety of distinct signals to grow, divide, and eventually die in a coordinated fashion. Cancer arises when cells escape normal growth control and fail to die. Considerable knowledge of oncogenesis and tumor development has been gained using cellular and animal cancer models. It is clear that oncogenic transformation is a complex process that involves multiple steps of genetic and cellular alterations. During this process, cells destined for oncogenic transformation progressively acquire capabilities of self-sufficiency in growth signals, insensitivity to antigrowth signals, limitless replicative potential, evasion of apoptotic signals, tissue invasion and metastasis, and sustained angiogenesis (Hanahan and Weinberg, 2000) . Although identification of various oncogenes and tumor suppressor genes has greatly advanced our understanding of the steps associated with cancer formation, the underlying cellular signaling networks governed by individual oncogenes or tumor suppressor genes remain poorly understood at the molecular level. One important reason for this major gap is the lack of appropriate human cancer models and subsequently the ability to systematically analyse these model systems.
Although primary rodent cells can be readily transformed by two cooperating oncogenes (Land et al., 1983; Ruley, 1983) , oncogenic transformation of human primary cells was achieved only recently by introducing a combination of the SV40 T/t oncogenes, the telomerase catalytic subunit gene (hTERT), and an oncogenic allele of H-RAS V12 (Hahn et al., 1999) . With the advent of this methodology, malignant transformation has been demonstrated in a variety of human cell lines using the same set of defined genetic elements. These systems include human embryonic kidney cells and foreskin fibroblasts (Hahn et al., 1999) , primary airway epithelial cells (Lundberg et al., 2002) , primary mammary epithelial cells (Elenbaas et al., 2001) , mesothelial cells (Yu et al., 2001) , and astrocytes (Rich et al., 2001) . Recently, a genetically defined model for human ovarian cancer has also been established using normal human ovarian surface epithelial (HOSE) cells . The observation that a few discrete genetic alterations can transform human cells in vitro supports the notion that there may be common molecular pathways associated with the seemingly complex and diverse phenotypes of cancer. Equally important, these model systems provide an opportunity to study the complex processes of tumorigenesis, especially the dissection of the functional roles of individual tumor promoter and suppressor genes in oncogenic transformation of human cells from different organ sites (Watnick et al., 2003; Young et al., 2004) .
The small GTPase RAS has long been known to play a significant role in tumor formation and development. RAS mutations are found in 30% of all human cancers (Bos, 1989) . Although multiple mediators of RAS signaling, including Raf, PI3 kinase, AF-6, and Ral-GDS, have been discovered, the exact role that oncogenic RAS plays in the multistep process of oncogenesis is not completely understood and many downstream functions of RAS signaling in cellular transformation remain a mystery. In the current study, we applied a proteomics approach to analyse a transformation model in which normal HOSE cells are immortalized by SV40 T/t oncogenes and hTERT, and further transformed through the addition of the constitutively active H-RAS
V12
. Proteomics provides a powerful tool for the systematic analysis of alterations in protein expression and post-translational modifications, and has been successfully applied recently for identifying tumor markers in bladder squamous cell carcinomas (Ostergaard et al., 1997) , hepatoma (Yu et al., 2000) , and melanoma (Bernard et al., 2003) . By profiling the protein expression differences between two genetically defined cell lines from an ovarian cancer model using two-dimensional gel electrophoresis (2-DE), we have identified numerous proteins and several specific cellular pathways associated with RASmediated oncogenic transformation. Many of these targets are novel downstream molecules that have not previously been linked to RAS signaling pathways or transformation. Results from our study not only provide further insights into our understanding of the RAS-mediated tumorigenic transformation process but also offer a novel approach for studying cancer signaling globally.
Results

2-DE gel analysis
To explore the molecular mechanisms of H-RAS mediated oncogenic transformation, comparative protein profiling was performed using two well-defined cell lines, T29 and T29H, derived from HOSE. While T29 cells, stably transfected with SV40 T/t antigens and hTERT, are fully immortalized, only the addition of oncogenic RAS leads to the malignant transformation of T29H cells as demonstrated by the capability of anchorage-independent growth and tumor formation in nude mice. Extracts from each cell line were analysed in triplicate by 2-DE. From preliminary studies using a 3-10 pH gradient, we concluded that the majority of 2-DE detectable proteins fell within a pH range of 5-7 on the gel. Therefore, a pH gradient of 4-7 was used in the first dimension to obtain maximal resolution of protein spots. We also found that the use of 10% tricine-SDS polyacrylamide gels, instead of glycine-SDS gradient gels, achieved a better dynamic separation range and reproducibility. For each cell line, at least two independent cell lysates were obtained from cultures at different early passages and four or more well-resolved gels from six different runs were analysed. Figure 1 shows representative 2-DE images of T29 and T29H; approximately 2200 distinct protein spots were resolved within each gel.
The intensity of each protein spot was determined, normalized to the sum of intensities of all spots on the gel, and quantified as a percentage volume in each gel using Phoretix 2-D analysis software (Nonlinear). Each individual protein spot was then matched with the identical protein spot from each replicate gel. Data for these matched spots were then averaged over replicate gels for each cell line. The average normalized volume of each spot in the transformed T29H cells was then compared to that of the matched spot in immortalized T29 cells. In order to determine what would constitute significant changes between transformed and untransformed cells, the intrinsic variance of each protein spot was determined for each cell line. The average variance for individual spots in the replicate gels for the T29 immortalized cell line was 34%. The average variance in the transformed T29H cell line was similar at 29% (Figure 2 ). These intrinsic variances determined the basal noise levels of our 2-DE analysis. Based on these observed values, we selected spots whose average normalized volume increased or decreased by at least 50% between the T29 and T29H cell lines as significantly changed candidates. We further narrowed the field of potential differentially changed protein by eliminating spots with greater than 50% variance. Finally, two independent observers examined the spots visually to confirm that changes from automated imaging analysis were real and reproducible. The final analysis revealed 80 protein spots that differed between immortalized T29 cells and H-RAS V12 transformed T29H cells. Of these spots, 56 showed increased levels while 14 showed decreased levels in T29H cells. Furthermore, three spots were present only in H-RAS transformed T29H cells while seven were absent.
Identification of putative protein targets involved in RAS-mediated oncogenic transformation
Of the 80 protein spots showing significant changes in protein levels after oncogenic transformation by RAS, we successfully identified 32 of them from 34 protein spots by peptide mass fingerprinting. As shown in Table 1 , the apparent observed molecular mass and isoelectric point for all identified proteins matched very well with their calculated values.
Most of these proteins could be classified into five general groups according to their cellular function, including apoptosis/proteolysis, calcium signaling, cellular methylation, metabolism, and redox homeostasis ( Table 2 ). The largest protein group consisted of enzymes involved in cellular metabolism. A total of 10 proteins have been identified within this category and most of these proteins were upregulated. In conjunction, five cellular enzymes involved in metabolizing reactive oxidative species (ROS) and maintaining redox balance in cells were also found to be upregulated. The upregulation of the ROS-related enzymes argued for a potential increase in cellular antioxidant capacity that could protect cells from excessive oxidative stress associated with H-RAS-mediated transformation (Young et al., 2004) . In addition, several calciumbinding proteins, including calretinin, calponin 3, and calpain small regulatory subunit 1, were modulated following H-RAS transformation (Figure 3 ). These proteins are enzymes involved in calcium homeostasis and signaling. Interestingly, two protein spots (7 and 8) with identical molecular weight and slightly different observed pIs of 5.8 and 6.1 were identified as the same calcium binding protein, acidic calponin 3. Both spots showed a 2-to 2.5-fold increase in protein level in the T29H cells. This type of change in calponin 3 pI, with little or no alteration in molecular mass, suggested possible post-translational modification, such as phosphorylation.
Post-translational regulation of caspase 4 maturation by RAS oncogenic transformation
Expression levels of several proteases, including cathepsin D, calpain, and procaspase 4, were altered in HOSE cells oncogenically transformed by H-RAS. One apoptosis related cysteine protease, the B40 kDa proform of caspase 4, was upregulated about four-fold in T29H cells in our 2-DE gel analysis (Figure 4a ). The increased level in procaspase 4 was further confirmed by immunoblotting analysis using caspase 4 specific antibodies ( Figure 4b) . Surprisingly, when the cellular activities of caspase 4 in T29 and T29H cells were measured using a caspase 4 specific substrate, we found that the actual basal cellular caspase 4 activity was Figure 1 Proteomic analysis of T29 and T29H cells using 2-DE gels. Whole-cell lysates (200 mg) from T29 (a) and T29H (b) HOSE were separated on 2-DE gel and visualized by silver staining as described in 'Materials and methods'. Arrows indicate identified protein spots significantly altered between T29 and T29H cells as listed in Table 1 Figure 2 Statistical analysis of intrinsic variance of protein spots identified in 2-DE gels. Average standard derivations of normalized spot volume of individual protein spot for T29H and T29 cell lines. The average variance for individual spots in the replicate gels (n ¼ 4) for the T29 immortalized cell line was 34%. The average variance in the transformed T29H cell line in the replicate gels (n ¼ 4) was similar at 29% Proteomic analysis of ras-mediated oncogenic transformation T Young et al Protein fold change was calculated using Nonlinear Phoretix 2-D Advanced software as described in Material and methods. Positive and negative numbers indicate increases and decreases in protein levels, respectively, in Ras-transformed T29H cells relative to T29 cells. The spot numbers correspond to those on the master images shown in Figure 1 Proteomic analysis of ras-mediated oncogenic transformation T Young et al Calpain is a calcium-dependent protease involved in apoptotic cascades Figure 3 Identified cellular calcium binding proteins significantly altered in T29H cells. While protein levels of calponin 3 were increased for 2.5 (left arrow) and 2.0 (right arrow) folds, the levels of calpain 1 and copine 1 were decreased for 1.5-and 2.8-folds in T29H cells, respectively. The calretinin spot was detected only in gels for T29H cells Proteomic analysis of ras-mediated oncogenic transformation T Young et al decreased in T29H cells (Figure 4c ). Since the active state of caspase 4 consists of a tetramer of P20 and P10 subunits derived from the proteolytic processing of procaspase 4, this decrease in enzymatic activity coupled with an apparent increase in the proform of caspase 4 protein in T29H cells suggested that maturation and activation of this enzyme were blocked in T29H cells following H-RAS transformation. To determine if RAS activation is directly responsible for suppressing the processing of procaspase 4 in T29H cells, the effect of selectively silencing cellular RAS on the levels of procaspase 4 in T29H cells was examined. Expression of two retroviral-mediated siRNA vectors, H1-siRNA, which targets the H-RAS V12 mutation, and H2-siRNA, which targets sequences in the wild-type H-RAS, significantly reduced the levels of procaspase 4 (Figure 4d) to that of T29. To further confirm that activation of RAS pathways was important for suppressing the maturation and activation of caspase 4 in T29H cells, we monitored the levels of procaspase 4 in T29H cells in response to various specific inhibitors that target the RAS downstream effectors MEK and PI3K. Inhibition of MEK by U0126 led to a significant reduction of procaspase 4 protein level while LY294002, a PI3 Kinase specific inhibitor, had little effect on the level of procaspase 4 (Figure 4e ). These results clearly demonstrated that activation of RAS and its downstream MAP kinase pathway was directly responsible for the suppression of caspase 4 processing and maturation in T29H cells.
RAS suppresses caspase 4 maturation and Fas-mediated apoptosis
Caspase 4 activation has been implicated in Fasmediated apoptosis (Kamada et al., 1997; Martin and Panja, 2002) . The apparent increased level of procaspase 4 protein and decreased caspase 4 activity in T29H cells led us to hypothesize that oncogenic RAS may be protecting the transformed T29H cells from Fasmediated apoptosis by suppressing the maturation of caspase 4 and/or other related proteases involved in cellular apoptosis. To test this hypothesis, we subjected the T29 and T29H cells to an agonist anti-Fas antibody CH11 (Upstate Biotechnology) that crosslinks the death receptor Fas and leads to the formation of a deathinducing signaling complex. As shown in Figure 5 , treatment of CH11 antibody led to massive cell death and significant apoptosis indicated by the activation of caspase 3 in T29 cells, while the transformed T29H cells were not significantly affected by CH11 treatments under the same conditions. When cell lysates from T29 and T29H cells treated with CH11 antibody were probed with a caspapse 4 specific antibody, activation of caspase 4 as monitored by the formation of active caspase 4 P20 and P10 subunits was observed in T29 cells, while significantly less P20 and P10 subunits and a concomitant increase in caspase 4 intermediates were detected in T29H cells (Figure 5c ). These results further confirmed that RAS mediated oncogenic transformation blocked the maturation of caspase 4 and attenuated Fas-mediated apoptosis in HOSE cells under the conditions described.
Discussion
Extensive studies have been conducted to discern the signaling pathways activated by the oncogene RAS in revealed by immunoblotting analysis using caspase 4 specific antibodies. (e) Protein levels of procaspase 4 in T29, T29H, and T29H treated with MEK specific inhibitor U0126 and PI3K specific inhibitor LY294006 revealed by immunoblotting analysis using caspase 4 specific antibodies Proteomic analysis of ras-mediated oncogenic transformation T Young et al the last 20 years. RAS mutations have been found in about 30% of all human cancers, and many lines of evidence support a primary role for RAS signaling pathways in ovarian cancer specifically. Mutations in K-RAS and its downstream effector B-RAF are frequently detected in serous borderline and low-grade serous carcinoma (Singer et al., 2003; Sieben et al., 2004) . Activating mutations of H-RAS are present in about 6% of ovarian cancers (Varras et al., 1999) . Moreover, activation of H-RAS upstream and downstream effector pathways is often demonstrated in the absence of H-RAS mutation (Patton et al., 1998) . For example, the upstream signaling molecule Her-2/Neu and immediate downstream RAS effector B-RAF were found to be upregulated and active in a large portion of ovarian cancers (Berchuck et al., 1990; Gemignani et al., 2003) . Most importantly, the RAS-transformed human ovarian cancer model used in this study exhibits many similar features of natural ovarian tumors. Gene expression profile analysis reveals that both RAStransformed cells and naturally derived ovarian cancer cells use the NF-kB pathway to activate cytokines and facilitate tumor formation . Although it is clear that RAS plays an important role in tumorigenesis, the molecular mechanism of RAS-mediated oncogenic transformation as a whole has not yet been identified. We chose a proteomics approach to systematically analyse the alterations in the cellular proteome of this model system of human ovarian epithelial cells transformed by H-RAS. The use of a genetically defined cancer transformation model allows the dissection of downstream signaling pathways specifically associated with RAS-mediated oncogenic transformation, while our proteomic analysis enabled the identification of numerous changes in protein expression as well as possible post-translational processing and proteolytic cleavage that are not amenable to genomic analysis. This is underscored by the fact that only about 15% of all target proteins identified by the proteomic approach in this study showed concomitant changes in mRNA abundance as detected by cDNA expression array .
Proteins identified in our 2-DE proteomic screen of H-RAS transformed cells included those that are involved in multiple cellular processes such as metabolism, redox regulation, calcium signaling, apoptosis, and cellular methylation ( Table 2 ). The largest group of proteins identified consisted of enzymes involved with metabolic processes. This was not surprising since tumor cells often require higher metabolic levels to maintain a growth advantage over normal cells and was consistent with the notion of increased energy demands in cancer cells (Argiles and Azcon-Bieto, 1988) . Several of these metabolic enzymes, including aldehyde dehydrogenase 2, ornithine aminotransferase, and enoyl-CoA hydratase were previously implicated in tumor formation (Matthaei and Williams, 1987; Lindahl, 1992; Balabanov et al., 2001) . Interestingly, several proteins involved in metabolizing reactive oxygen species and maintaining redox balance were also upregulated in T29H cells. Upregulation of these antioxidant proteins allows T29H cells to offset high levels of reactive oxygen species that are associated with increased metabolism. This increase in antioxidant proteins confers resistance to ROS mediated apoptosis in RAS transformed cells (Young et al., 2004) . Many of the identified protein targets, including calretinin, cathepsin D, glyoxylase I, aldehyde dehydrogenase 2, and the calcium dependent protease Calpain 1, are associated with cancer development or RAS signaling. Calretinin, a mediator of intracellular calcium responses (Rogers et al., 1990) , is a biomarker used in diagnoses of cancers, including epithelial ovarian tumors (Cao et al., 2001) . Cathepsin D has been implicated in numerous studies as a cysteine protease involved in extracellular proteolysis of the basement membrane and metastasis to foreign tissue. Upregulation of cathepsin D is associated with poor prognosis in breast and ovarian cancer patients (Losch et al., 2004) . Transformation by oncogenic RAS has been shown to alter the processing and intracellular trafficking of lysosomal cathepsin D (Demoz et al., 1999) and to upregulate cathepsin D activity in human breast epithelial cell lines (Calaf et al., 1994) . In addition, glyoxylase I has been recently identified as a biomarker for ovarian cancer (Jones et al., 2002) , while the expression of aldehyde dehydrogenase 2 is altered significantly in hepatocellular carcinomas (Park et al., 2002) . The 28 kDa calpain subunit is the regulatory arm of the calpain system. This subunit binds to calcium and modulates the activity of the calpain protease (Goll et al., 2003) The calpain system is known to mediate cellular signaling pathways associated with cell proliferation, differentiation and death in response to increases in intracellular Ca 2 þ . For example, calpain is implicated as a downstream effector of the G q signaling pathway for inhibition of Wnt/b-catenin-regulated cell proliferation (Li and Iyengar, 2002) . Calpain has also been reported to be important for ERK/MAP kinase activation associated with epidermal growth factor receptor-mediated fibroblast motility (Glading et al., 2000) and for integrin-induced signaling upstream of Rho GTPases (Kulkarni et al., 1999) . In addition, calpain is involved in caspase-independent apoptosis in ovarian and breast cancers (Bao et al., 2002) . The alteration of these known cancer associated proteins and biomarkers further supports our H-RAS mediated transformation model as a mimic of naturally occurring cancers in vivo. In addition, the ability to identify these biomarkers and cancer-related proteins also validates our proteomic approach in studying the mechanism of oncogenic transformation.
Of the proteins identified, only about 50% had a connection with H-RAS signaling or oncogenic transformation established in the literature. The remainder consisted of proteins with no known association with RAS signaling or transformation. These proteins present a unique opportunity to delineate new pathways that might be involved in the transformation process mediated by H-RAS. For example, we identified an apparent upregulation of procaspase 4 in the RAStransformed cells. Since caspase 4 activity depends on cleavage of procaspase 4 into a smaller catalytically active enzyme, and given the fact that while levels of the procaspase 4 were increased, overall basal cellular caspase 4 activity was actually decreased (Figure 4c) , we concluded that the maturation of procaspase 4 was blocked at the post-translational level in RAS-transformed T29H cells. The fact that upregulation of procaspase 4 could be reversed by U0126, an MEK specific inhibitor, demonstrated that this inhibitory effect on caspase 4 maturation was directly mediated by the MAP kinase pathway downstream of RAS. This inhibitory mechanism could be due to a phosphorylation modification of procaspase 4 by MAP kinase, in a manner similar to procaspase 9 whose maturation has been shown to be blocked by H-RAS activation via phosphorylation at Thr125 (Allan et al., 2003) . The exact mechanism of RAS-mediated inhibition of caspase 4 activation is currently under further investigation. Caspase 4 has been implicated in the Fas-mediated apoptotic cascade (Kamada et al., 1997; Martin and Panja, 2002) and decreased sensitivity to Fas-mediated apoptosis has been shown to contribute to ovarian tumorigenesis. The apparent blockage of caspase 4 activation and resistance to Fas-mediated apoptosis suggest that RAS-mediated suppression of caspase 4 activation may allow H-RAS transformed cells to evade apoptosis.
In conclusion, this study demonstrates the value of applying a proteomics approach to identify novel effectors of H-RAS mediated transformation in human ovarian epithelial cells. Using this method, we have identified numerous proteins that are altered in association with RAS-mediated oncogenic transformation. The proteins identified demonstrate that H-RAS mediated transformation of ovarian epithelial cells affects many aspects of cellular functions, including the loss of sensitivity to apoptosis, and thus confers an aggressive oncogenic phenotype on cancer cells.
Materials and methods
Cell lines and culture methods
HOSE cells were immortalized and transformed as previously described . Briefly, isolated human surface ovarian epithelium cells were infected sequentially by retroviruses containing SV40 T/t antigens and hTERT genes to generate T29 cells. The immortalized but nononcogenic T29 cells were further transformed by introducing an oncogenic H-RAS V12 in a pLNCX retroviral vector to form the T29H cell line. Cells were cultured in MCDB105/Media 199 medium (1 : 1) containing 10% FBS and 1% penicillin/streptomycin. Immortalized cells containing the hTERT gene were selected using hygromycin (100 mg/ml) and transformed cells containing both hTERT and H-RAS V12 were selected with hygromycin and puromycin (1 mg/ml). Early passages of the T29 and T29H cells were used.
Preparation of total cell lysate
To obtain total protein lysates, 70-80% confluent T29 and T29H cells from 100 mm plates were trypsinized, pelleted, and Proteomic analysis of ras-mediated oncogenic transformation T Young et al suspended in 500-1000 ml lysis buffer (7 M urea, 2 M thiourea, 4% Chaps, 1 mM EDTA, 1 mM EGTA, 60 mM DTT, 1 mM PMSF, 1 mM benzamidine, 25 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mM microcystin, 10 mM sodium orthovanadate). Cells were lysed at room temperature for 1 h with occasional mixing and centrifuged at 180 000 g for 1 h at 221C to pellet insoluble cellular debris. Protein concentration of total cell lysate was determined using the Bio-Rad RC/DC Bradford assay that is compatible with detergents and reducing agents. Aliquots were loaded immediately onto gels or frozen in a dry ice/methanol bath and stored at -801C until use.
2-DE gel electrophoresis
In total, 200 mg of total protein was used in analytical gels for image analysis and spot identification, while 500 mg of total protein was used in preparative gels for protein identification. Samples in 350 ml of lysis buffer containing 0.5% IPG buffer (pH 4-7) was applied onto Immobilin dry strips (pH 4-7, 18 cm, Pharmacia Biosciences) and allowed to rehydrate at 201C for 12 h. Isoelectric focusing was performed at 201C on an IPGphor unit (Pharmacia Biosciences) for 1 h at 500 V, 1 h at 1000 V, followed by a gradient from 1000 to 8000 V in 1 h and 6 h at 8000 V. After focusing, strips were either immediately loaded onto polyacrylamide gels or frozen at -801C. Large format (20 Â 20 cm 2 ) 10% tricine-SDS gels were poured fresh the day of use. Before the second dimension, strips were incubated in reducing buffer (6 M urea, 2% SDS, 50 mM Tris, 30% glycerol, 65 mM DTT, pH 6.8) for 15 min with shaking at room temperature, followed by 15-min incubation in alkylation buffer (6 M urea, 2% SDS, 0.375 M Tris, 30% glycerol, 240 mM iodoacetamide, pH 8.8), and then loaded onto the second-dimension gel, sealed with 0.5% low-melting agarose in running buffer at the top. The second dimension was performed on a Bio-Rad Protean IIxi 2D unit at a constant voltage of 140 for 22 h. During the entire course of the electrophoresis, the temperature of the gels was maintained at a constant 121C by a circulating water bath to maximize separation resolution. Analytical gels used for image analysis were stained as described previously (Blum et al., 1987) . Preparative gels used for identification of proteins were stained using a low fixation silver protocol (Shevchenko et al., 1996) .
Image analysis
Digital gel images were obtained using a CCD camara (Alpha Innotech imager 5500). Gel images were then analysed using Phoretix 2-D Advanced software (Nonlinear). This software identifies protein spots within each image and matches identical protein spots across all images. A total of six gels from at least two independent cell lysate preparations were used from each cell line. Once spots were matched, images were manually edited to confirm proper spot detection and matching. The intensity of each protein spot was normalized as a percentage of total volume, corresponding to pixel intensity integrated over the area of each spot and divided by the sum of all spots in the gel to account for staining variability. Following manual editing and matching confirmation, average normalized spot volumes (pixel intensity over spot area) were compared between T29 and T29H cells. Target candidates were identified as protein spots that changed at least 1.5-fold between immortalized (T29) and transformed (T29H) cell lines and that were either present or absent in one cell line or the other. Protein spots with greater than 50% internal variance were removed from the target list. Finally, remaining individual candidates were visually examined to ensure that the change was consistent in all gels.
Tryptic in-gel digestion and mass spectrometry
Protein spots were punched out from multiple wet preparative gels using clean pipette tips with their ends cut to match the size of the spot. Gel pieces from 1 to 4 or 8 to 10 gels were pooled for high and low abundance spots, respectively. Excised gel plugs were washed with 100 mM NH 4 CO 3 and 50% acetonitrile (ACN)/50 mM NH 4 CO 3 each for 20 min and subsequently dehydrated in 50 ml of ACN for 10 min. The dried gel pieces were rehydrated in 10 ml of sequencing grade trypsin (Promega) in 25 mM NH 4 CO 3 to a final concentration of 20 mg/ml trypsin and digested overnight at 371C. Supernatant containing tryptic fragments was transferred to a clean tube and gel pieces were extracted twice with 30 ml of 60% ACN/0.1% trifluoroacetic acid for 20 min in a sonicating water bath. Peptides mixtures were pooled, dried down in a SpeedVac, and resuspended in 5 ml of 0.1% formic acid.
Digested peptide samples were cocrystallized with an equal volume of a-cyano-4-hydroxy-trans-cinnamic acid matrix (Hewlett Packard) on a gold-coated sample plate and analysed by MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry (Voyager-DE STR, Applied Biosystems) to obtain peptide masses. Data were summed over 150 acquisitions in delayed extraction mode, with sensitivity B10 fmol (20 kV accelerating voltage, 10 V guide wire voltage, 100 ns delay). Internal calibrations were performed using tryptic autolysis peaks at 842.5090 and 2211.1064 Da. Peptide mass data were analysed by searching against the National Center for Biotechnology Information (NCBI) nonredundant database using Protein Prospector (http://prospector.ucsf.edu/ , University of California, San Francisco) and Profound (http://prowl.rockefeller.edu/cgi-bin/ProFound, Rockefeller University), with mass tolerance of 0.13 Da and allowing one missed cleavage and peptide modifications by acrylamide adducts with cysteine and methionine oxidation. Proteins identified by peptide mass fingerprinting were further evaluated by comparing the calculated and observed molecular mass and pI, as well as the number of peptides matched and percent sequence coverage.
Immunoblotting analysis
Protein concentration of cell lysates was assayed with the BioRad protein assay reagent. Equal amounts of protein (30 mg) were loaded onto 12% SDS polyacrylamide mini-gels (BioRad), transferred to PVDF membranes. PVDF blots and the remaining polyacrylamide gels were stained with Ponceau S and Coomassie Blue, respectively, to ensure equal loading and even transfer of the samples. After being blocked overnight in 5% milk in TBS-Tween, blots were incubated with AntiCaspase-4 P-20 antibody (1 : 1000, Santa Cruz) for 1.5 h, followed by HRP-conjugated secondary antibody (1 : 4000, Chemicon) for 45 min. Antigen-antibody complexes were detected by enhanced chemiluminescence (Pierce).
Caspase activity assays
T29 and T29H cells were grown in 100 mm plates to 70-80% confluence, then harvested by trypsinization, washed twice in PBS and once in wash buffer (100 mM HEPES pH 7.4, 0.5 mM EDTA, 1 mM DTT, protease inhibitors 0.1 mM PMSF, 2 mg/ml leupeptin, 2 mg/ml pepstatin). The cells were lysed on ice for 30 min with frequent vortexing in 150 ml of lysis buffer (wash buffer plus 1% Triton X-100). Cell debris was removed by centrifugation at 16 000 g for 20 min at 41C. Lysate protein concentration was determined by Bradford assay (Bio-Rad). Caspase 3 and 4 activities were measured using fluorogenic substrates DEVD-AFC and Ac-LEVD-AFC that are specific for caspases 3 and 4, respectively, by monitoring the release of free AFC as determined using a Fluoroskan fluorescence microplate reader with excitation and emission set to 405 and 510 nm, correspondingly.
Inhibition of H-RAS gene expression by siRNA
T29H cells were transfected with either one of the two retrovirus-mediated H-RAS siRNA vectors (designated as H1 and H2) that have been described previously (Yang et al., 2003) . Briefly, H1 selectively silences mutant H-RAS V12 while H2 suppresses both mutant and wild-type H-RAS expression. T29H cells were infected with H1 and H2 retrovirus generated from Phoenix cells and selected for 7-10 days in 0.7 mg/ml of G418 to establish stable cell lines. The expression and activation levels of H-RAS proteins in these siRNA stable cell lines were assayed by immunoblotting analysis and RAS activity assay using GST-Raf-RBD (Young et al., 2004) , respectively.
CH11 antibody treatment
T29 and T29H cells were plated at 1 Â 10 4 cells/well in 12-well plates and grown for 24 h. Cells were then treated with CH11 anti-Fas antibody (Upstate Biotechnology) at concentrations ranging from 25 to 300 ng/ml in medium with 10% fetal bovine serum that had been inactivated at 561C for 30 min. After 96 h, cells were examined under phase contrast microscope. For determination of Caspase 3 activity, cells were grown in 10 cm culture plates for 24 h and treated with 0, 25, 100, and 200 ng/ ml CH11 for 96 h and subsequently harvested for caspase 3 activity measurements.
Abbreviations 2-DE, two-dimensional electrophoresis; ACN, acetonitrile; HOSE, human ovarian surface epithelia cells; hTERT, human telomerase catalytic subunit; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight.
